Jane Worthington Selected Research

Jane Worthington Research Topics

Disease

49	Rheumatoid Arthritis 01/2019 - 01/2002
12	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2019 - 01/2004
10	Autoimmune Diseases (Autoimmune Disease) 10/2018 - 03/2004
9	Systemic Scleroderma (Systemic Sclerosis) 08/2016 - 08/2010
6	Arthritis (Polyarthritis) 04/2015 - 01/2004
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 06/2005
4	Genetic Predisposition to Disease (Genetic Predisposition) 08/2016 - 03/2011
3	Necrosis 01/2016 - 10/2007
3	Disease Susceptibility (Diathesis) 04/2015 - 01/2005
3	Psoriatic Arthritis 06/2011 - 01/2004
3	Joint Diseases (Joint Disease) 01/2010 - 06/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013 - 06/2005
2	Crohn Disease (Crohn's Disease) 11/2005 - 03/2005
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2003 - 06/2003
1	Hypersensitivity (Allergy) 01/2019
1	Rheumatic Diseases (Rheumatism) 01/2019
1	Pulmonary Arterial Hypertension 10/2017
1	Familial Primary Pulmonary Hypertension 10/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Genetic Risk Score 01/2015
1	Schizophrenia (Dementia Praecox) 11/2014
1	Neoplasms (Cancer) 02/2014
1	Infections 05/2013
1	Hypoxia (Hypoxemia) 12/2012
1	Fibrosis (Cirrhosis) 12/2012
1	Multiple Sclerosis 01/2009
1	Graves Disease (Basedow Disease) 01/2009
1	Celiac Disease (Celiac Sprue) 03/2008
1	Lipoma (Lipomata) 03/2008

Drug/Important Bio-Agent (IBA)

11	HLA-DRB1 Chains (HLA DRB1)IBA 04/2015 - 09/2003
9	AutoantibodiesIBA 04/2014 - 06/2005
8	Proteins (Proteins, Gene)FDA Link 01/2015 - 10/2003
6	Peptides (Polypeptides)IBA 03/2015 - 01/2012
5	Pharmaceutical PreparationsIBA 01/2019 - 05/2013
5	EpitopesIBA 01/2012 - 03/2004
4	HLA-C Antigens (HLA-C)IBA 08/2019 - 11/2010
4	Biological ProductsIBA 01/2019 - 01/2013
4	CytokinesIBA 10/2017 - 09/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 10/2007
3	Amino Acids FDA Link 04/2015 - 01/2012
3	TNF Receptor-Associated Factor 1IBA 02/2013 - 01/2010
3	Genetic Markers (Genetic Marker)IBA 02/2013 - 07/2011
3	Rheumatoid FactorIBA 10/2012 - 01/2004
2	ChromatinIBA 01/2019 - 01/2019
2	P-2 (P 2)IBA 10/2017 - 03/2008
2	cyclic citrullinated peptideIBA 01/2016 - 09/2009
2	Anti-Citrullinated Protein AntibodiesIBA 01/2016 - 04/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2015 - 04/2014
2	AntibodiesIBA 03/2015 - 12/2012
2	HLA-DPB1 antigen (HLA DPB1)IBA 01/2015 - 01/2012
2	HLA-B Antigens (HLA-B)IBA 01/2015 - 01/2012
2	AntigensIBA 01/2015 - 06/2007
2	Protein Tyrosine PhosphatasesIBA 07/2013 - 05/2007
2	Interleukin-2 (IL2)IBA 07/2013 - 03/2008
2	interleukin-21 (interleukin 21)IBA 07/2013 - 03/2008
2	Interleukin-13IBA 01/2012 - 06/2011
2	Macrophage Migration-Inhibitory FactorsIBA 11/2011 - 09/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 08/2008
2	Protein-Arginine DeiminasesIBA 04/2004 - 10/2003
1	Deoxyribonucleases (DNase)FDA Link 01/2019
1	histone H3 trimethyl Lys4IBA 10/2018
1	Monoclonal AntibodiesIBA 11/2016
1	interleukin 20 (IL-20)IBA 11/2016
1	Interleukin-12 (IL 12)IBA 08/2016
1	Protein Kinases (Protein Kinase)IBA 08/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Etanercept (Enbrel)FDA Link 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	anti-scl-70 autoantibodiesIBA 07/2015
1	Syndecan-2IBA 06/2015
1	Valine (L-Valine)FDA Link 04/2015
1	Tumor Necrosis Factor InhibitorsIBA 04/2015
1	ElementsIBA 11/2014
1	Methyl-CpG-Binding Protein 2IBA 12/2013
1	Transcription Factors (Transcription Factor)IBA 05/2013
1	Small Interfering RNA (siRNA)IBA 05/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2013
1	PotassiumIBA 12/2012
1	Interleukin-6 (Interleukin 6)IBA 12/2012
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2012
1	HLA-A Antigens (HLA-A)IBA 01/2012
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2012
1	HLA-DQA1 antigen (HLA DQA1)IBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2012
1	MHC class II transactivator proteinIBA 01/2012
1	IgG Receptors (Fc gamma RI)IBA 08/2010
1	Protein-Arginine Deiminase Type 4IBA 04/2010
1	ametantrone (HAQ)IBA 01/2010
1	Interleukin-2 Receptor alpha SubunitIBA 01/2009
1	Interleukin-15 (Interleukin 15)IBA 12/2008
1	Interleukin-23 (Interleukin 23)IBA 12/2008
1	Antirheumatic Agents (DMARD)IBA 11/2008
1	multidrug resistance-associated protein 1IBA 08/2008
1	Adenosine Triphosphate (ATP)IBA 08/2008
1	Methotrexate (Mexate)FDA LinkGeneric 08/2008
1	HLA-DR Antigens (HLA-DR)IBA 12/2007
1	Interleukin-1 (Interleukin 1)IBA 10/2007
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2007

Therapy/Procedure

11	Therapeutics 01/2019 - 01/2005